Table 2 Baseline characteristics of PD patients and controls from the first stage of the study.
PD | Controls | |
|---|---|---|
Number | 55 | 65 |
Mean age (SD) | 66.8 (9.6) | 71.2 (9.5) |
Gender | ||
Female | 24 (44%) | 36 (55%) |
Male | 31 (56%) | 29 (45%) |
Education | ||
Primary | 3 (5%) | – |
Secondary | 24 (44%) | – |
Higher | 10 (18%) | – |
Further | 18 (33%) | – |
Occupation | ||
Professional | 25 (46%) | – |
Non-professional skilled | 9 (16%) | – |
Non-professional/non-skilled | 21 (38%) | – |
Mean yrs since PD diagnosis (SD) | 6.3 (4.9) | – |
Most affected side | ||
Right | 17 (31%) | – |
Left | 36 (65%) | – |
Equally | 2 (3%) | |
Levodopa | ||
Yes | 50 (91%) | – |
No | 5 (9%) | – |
Median minutes since levodopa dose (IQR) | 150 (60, 210) | – |
% Patients who had taken Levodopa < 12 h | 50 (100%) | |
On/Offa | ||
On | 48 (96%) | – |
Off | 2 (4%) | – |
Mean MDS-UPDRS-III total (SD) | ||
On (n = 48) | 38.2 (16.4) | |
Off (n = 2) | 67.5 (6.4) | |
Mean MDS-UPDRS finger tapping subscore (SD) | ||
Off (n = 48) | 3.8 (1.6) | |
On (n = 2) | 5.5 (0.7) | |
